CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q121 Q221 Q321 Q421 Q122 Q222 Q322 Q422 Q123 Revenues: Clearing and transaction fees 1,007.0 929.9 878.9 949.3 1,138.1 1,024.6 998.6 981.4 1,200.2 Market data and information services 144.2 145.2 145.4 142.1 151.7 151.7 154.3 153.2 165.8 Other Revenue 102.1 104.1 85.6 55.9 56.8 60.9 74.9 73.2 75.6 Total revenues 1,253.3 1,179.2 1,109.9 1,147.3 1,346.6 1,237.2 1,227.8 1,207.8 1,441.6 Expenses: Compensation and benefits 225.0 211.7 198.6 201.7 185.2 185.3 189.6 193.0 204.5 Technology 48.2 49.3 49.3 45.8 45.9 45.9 46.8 50.0 51.3 Professional fees and outside services 37.4 36.8 45.2 32.3 31.8 32.0 35.1 38.5 38.3 Amortization of purchased intangibles 60.6 59.4 59.0 58.6 58.4 57.1 55.5 56.7 56.8 Depreciation and amortization 37.6 37.1 37.2 35.9 33.5 33.0 34.5 33.9 31.9 Licensing and other fee agreements 64.7 54.2 57.6 60.4 80.9 83.1 83.6 72.4 84.7 Other expense 54.7 56.0 49.3 80.9 51.8 51.1 43.9 95.0 60.4 Operating expenses 528.2 504.5 496.2 515.6 487.5 487.5 489.0 539.5 527.9 Operating Income 725.1 674.7 613.7 631.7 859.1 749.7 738.8 668.3 913.7 Operating Margin 58% 57% 55% 55% 64% 61% 60% 55% 63% Non-operating Income and Expense Investment income 30.9 62.4 145.8 67.8 73.1 286.9 686.2 1,152.2 1,357.7 Interest and other borrowing costs (41.5) (41.7) (41.8) (41.9) (42.5) (39.9) (40.4) (39.9) (39.9) Equity in net gains (losses) of unconsolidated subsidiaries 56.2 55.7 66.4 67.5 73.3 87.3 76.5 64.0 78.2 Other non-operating income (expense) (18.4) (25.0) 311.8 74.2 (46.7) (217.3) (581.1) (1,017.3) (1,152.8) Non-operating income (expense) 27.2 51.4 482.2 167.6 57.2 117.0 141.2 159.0 243.2 Income before income taxes 752.3 726.1 1,095.9 799.3 916.3 866.7 880.0 827.3 1,156.9 Income taxes 177.5 215.5 169.6 174.1 205.3 204.2 200.4 189.4 273.1 Net income 574.8 510.6 926.3 625.2 711.0 662.5 679.6 637.9 883.8 Less: net income (loss) attributable to NCI 0.4 0.3 (0.2) - - - - - - Net Income Attributable to CME Group 574.4 510.3 926.5 625.2 711.0 662.5 679.6 637.9 883.8 Net Income Attributable to Common Shareholders of CME Group 574.4 510.3 926.5 613.3 702.0 654.1 671.1 629.9 872.7 Effective Tax Rate 23.6% 29.7% 15.5% 21.8% 22.4% 23.6% 22.8% 22.8% 23.6% Earnings per Share Attributable to Common Shareholders of CME Group: Basic EPS 1.60 1.42 2.59 1.71 1.96 1.82 1.87 1.76 2.43 Diluted EPS 1.60 1.42 2.58 1.71 1.95 1.82 1.87 1.75 2.43 Weighted average number of common stock shares: Basic Shares 358,147 358,261 358,363 358,582 358,609 358,641 358,715 358,885 358,933 Diluted Shares 358,817 358,888 358,988 359,019 359,180 359,205 359,288 359,190 359,313 Preferred Shares 2,890 4,584 4,584 4,584 4,584 4,584 -- 1 of 2 -- CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF NON-GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q121 Q221 Q321 Q421 Q122 Q222 Q322 Q422 Q123 Revenues: Clearing and transaction fees 1,007.0 929.9 878.9 949.3 1,138.1 1,024.6 998.6 981.4 1,200.2 Market data and information services 144.2 145.2 145.4 142.1 151.7 151.7 154.3 153.2 165.8 Other Revenue 102.1 101.0 85.6 55.9 56.8 60.9 74.9 73.2 75.6 Total revenues 1,253.3 1,176.1 1,109.9 1,147.3 1,346.6 1,237.2 1,227.8 1,207.8 1,441.6 Expenses: Compensation and benefits 207.5 201.9 191.1 183.7 182.8 189.5 189.1 184.6 192.8 Technology 47.7 49.2 49.1 45.6 45.8 45.9 46.8 50.0 51.3 Professional fees and outside services 27.9 30.0 26.5 27.2 30.3 31.4 35.1 38.5 38.3 Amortization of purchased intangibles - - - - - - - - - Depreciation and amortization 36.8 36.7 36.7 35.6 33.5 32.9 33.8 33.9 31.9 Licensing and other fee agreements 64.7 54.2 57.6 60.4 80.9 83.1 81.9 72.4 84.7 Other expense 52.1 54.8 51.3 76.5 51.7 59.6 54.4 84.5 59.7 Operating expenses 436.7 426.8 412.3 429.0 425.0 442.4 441.1 463.9 458.7 Operating Income 816.6 749.3 697.6 718.3 921.6 794.8 786.7 743.9 982.9 Operating Margin 65% 64% 63% 63% 68% 64% 64% 62% 68% Non-operating Income and Expense Investment income 26.9 37.3 55.1 58.2 74.7 299.5 688.5 1,147.1 1,277.5 Interest and other borrowing costs (41.5) (41.7) (41.8) (41.9) (42.5) (39.9) (40.4) (39.9) (39.9) Equity in net gains (losses) of unconsolidated subsidiaries 56.2 55.7 70.5 78.7 84.7 98.2 89.6 76.2 91.5 Other non-operating income (expense) (18.4) (25.0) (32.9) (33.0) (43.4) (218.5) (585.7) (1,023.3) (1,160.6) Non-operating income (expense) 23.2 26.3 50.9 62.0 73.5 139.3 152.0 160.1 168.5 Income before income taxes 839.8 775.6 748.5 780.3 995.1 934.1 938.7 904.0 1,151.4 Income taxes 198.2 186.7 174.3 172.8 228.9 217.6 219.6 206.0 269.1 Net income 641.6 588.9 574.2 607.5 766.2 716.5 719.1 698.0 882.3 Less: net income (loss) attributable to NCI 0.4 0.3 (0.2) - - - - - - Net Income Attributable to CME Group 641.2 588.6 574.4 607.5 766.2 716.5 719.1 698.0 882.3 Net Income Attributable to Common Shareholders of CME Group 641.2 588.6 574.4 595.7 756.6 707.5 710.0 689.1 871.1 Effective Tax Rate 23.6% 24.1% 23.3% 22.1% 23.0% 23.3% 23.4% 22.8% 23.4% Earnings per Share Attributable to Common Shareholders of CME Group: Basic EPS 1.79 1.64 1.60 1.66 2.11 1.97 1.98 1.92 2.43 Diluted EPS 1.79 1.64 1.60 1.66 2.11 1.97 1.98 1.92 2.42 Weighted average number of common stock shares: Basic Shares 358,147 358,261 358,363 358,582 358,609 358,641 358,715 358,885 358,933 Diluted Shares 358,817 358,888 358,988 359,019 359,180 359,205 359,288 359,190 359,313 Preferred Shares - - - 2,890 4,584 4,584 4,584 4,584 4,584 -- 2 of 2 --